Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Medtronic PLC (MDT : NYSE)

• Company Description    Medtronic, Inc. acquired Ireland-based Covidien plc. The acquisition resulted in the formation of a new holding company incorporated in Ireland - Medtronic plc. The company currently generates revenues from four major segments - namely Cardiovascular Portfolio, Medical Surgical Portfolio, Neuroscience Portfolio and Diabetes. The Cardiovascular Portfolio, formerly reported as the Cardiac and Vascular Group, includes the Cardiac Rhythm & Heart Failure, Structural Heart & Aortic and Coronary & Peripheral Vascular divisions. The Medical Surgical Portfolio, formerly reported as the Minimally Invasive Therapies Group, includes the Surgical Innovations and the Respiratory, Gastrointestinal & Renal divisions. Neuroscience consists of Cranial & Spinal Technologies, Specialty The Neuroscience Portfolio, formerly reported as the Restorative Therapies Group, includes the Cranial & Spinal Technologies, Specialty Therapies, and Neuromodulation divisions. Number of Employees: 95,000

• Price / Volume Information    Yesterday's Closing Price: $92.20 Daily Weekly Monthly 20 Day Moving Average: 5,818,706 shares Shares Outstanding: 1,282.69 (millions) Market Capitalization: $118,263.62 (millions) Beta: 0.77 52 Week High: $99.37 52 Week Low: $79.29 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -3.40% -5.94% 12 Week -0.88% -4.99% Year To Date 15.42% 0.89%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL BUILDING TWO PARKMORE BUSINESS PARK WEST - GALWAY,L2 H91 IRL ph: 353-1438-1700 fax: 763-514-4879 investor.relations@medtronic.com http://www.medtronic.com

• General Corporate Information    Officers Geoffrey S. Martha - Chairman and Chief Executive Officer Thierry Pieton - Executive Vice President and Chief Financial Offic Matthew Walter - Senior Vice President Ivan K. Fong - Executive Vice President; General Counsel and Secr Denise L. Blomquist - Vice President; Global Controller and Chief Accoun Peer Information Medtronic PLC (BJCT) Medtronic PLC (CADMQ) Medtronic PLC (APNO) Medtronic PLC (UPDC) Medtronic PLC (IMTIQ) Medtronic PLC (CYGN) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED PRODUCTS Sector: Medical CUSIP: G5960L103 SIC: 3845 Fiscal Year Fiscal Year End: April Last Reported Quarter: 07/01/25 Next Expected EPS Date: 11/18/25 Share - Related Items Shares Outstanding: 1,282.69 Most Recent Split Date: 9.00 (2.00:1) Beta: 0.77 Market Capitalization: $118,263.62 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 3.08% Current Fiscal Quarter EPS Consensus Estimate: $1.35 Indicated Annual Dividend: $2.84 Current Fiscal Year EPS Consensus Estimate: $5.62 Payout Ratio: 0.51 Number of Estimates in the Fiscal Year Consensus: 12.00 Change In Payout Ratio: -0.01 Estmated Long-Term EPS Growth Rate: 6.76% Last Dividend Paid: 09/26/2025 - $0.71 Next EPS Report Date: 11/18/25

• Fundamental Ratios P/E Current FY Estimate: 16.42 Trailing 12 Months: 16.67 PEG Ratio: 2.43 Price Ratios Price/Book: 2.46 Price/Cash Flow: 11.90 Price / Sales: 3.46 EPS Growth vs. Year Ago Period: 2.44% vs. Previous Quarter: -22.22% Sales Growth vs. Year Ago Period: 8.38% vs. Previous Quarter: -3.91% ROE 10/31/25 - - 07/31/25 - 14.61 04/30/25 - 14.54 ROA 10/31/25 - - 07/31/25 - 7.85 04/30/25 - 7.83 Current Ratio 10/31/25 - - 07/31/25 - 2.01 04/30/25 - 1.85 Quick Ratio 10/31/25 - - 07/31/25 - 1.50 04/30/25 - 1.42 Operating Margin 10/31/25 - - 07/31/25 - 20.80 04/30/25 - 21.11 Net Margin 10/31/25 - - 07/31/25 - 13.63 04/30/25 - 13.90 Pre-Tax Margin 10/31/25 - - 07/31/25 - 16.56 04/30/25 - 16.78 Book Value 10/31/25 - - 07/31/25 - 37.53 04/30/25 - 37.62 Inventory Turnover 10/31/25 - - 07/31/25 - 2.12 04/30/25 - 2.12 Debt-to-Equity 10/31/25 - - 07/31/25 - 0.54 04/30/25 - 0.53 Debt-to-Capital 10/31/25 - - 07/31/25 - 35.23 04/30/25 - 34.70

Powered by Zacks Investment Research ©